Biomaterials for mRNA delivery
Open accessAbstract
Messenger RNA (mRNA) has recently emerged with remarkable potential as an effective alternative to DNA-based therapies because of several unique advantages. mRNA does not require nuclear entry for transfection activity and has a negligible chance of integrating into the host genome which excludes the possibility of potentially detrimental genomic alternations. Chemical modification of mRNA has further enhanced its stability and decreased its activation of innate immune responses. Additionally, mRNA has been found to have rapid expression and predictable kinetics. Nevertheless, the ubiquitous application of mRNA remains challenging given its unfavorable attributes, such as large size, negative charge and susceptibility to enzymatic degradation. Further refinement of mRNA delivery modalities is therefore essential for its development as a therapeutic tool. This review provides an exclusive overview of current state-of-the-art biomaterials and nanotechnology platforms for mRNA delivery, and discusses future prospects to bring these exciting technologies into clinical practice.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Different non-viral materials have been designed and optimized for accommodating efficient delivery of diverse RNA molecules as well as multi-component genome editing systems.
“Different non-viral materials have been designed and optimized for accommodating efficient delivery of diverse RNA molecules as well as multi-component genome editing systems.[22, 34–36]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [34]
For many GARDs, the liver is a preferred organ for mRNA-based PRTs because systemically administered mRNA vehicles are predominantly trapped by the reticuloendothelial system in the liver.
“For many GARDs, the liver is a preferred organ for mRNA-based PRTs because systemically administrated mRNA vehicles are predominantly trapped by the reticuloendothelial system (RES) in the liver.”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [34]
The interaction between apolipoprotein E and biomaterials such as lipid and lipid derived materials facilitates accumulation in the liver.
“In addition, the interaction between apolipoprotein E (apoE) and biomaterials such as lipid and lipid derived materials facilitates the accumulation in the liver.[8, 18, 34, 39, 59, 120, 121, 124, 164, 165]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282 · see citing works
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · see citing works
Shaw, G. D., & Kamen, R. (1986) · Cell · doi:10.1016/0092-8674(86)90341-7 · Cited by 3,946 · see citing works
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637 · see citing works
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444 · see citing works
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123 · see citing works
Design and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568 · see citing works
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501 · see citing works
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works
Gold Nanoparticles for Biology and Medicine
Giljohann, D. A., Seferos, D. S., Daniel, W. L., Massich, M. D., Patel, P. C., & Mirkin, C. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904359 · Cited by 2,356 · see citing works
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
Rosi, N. L., Giljohann, D. A., Thaxton, C. S., Lytton‐Jean, A. K. R., Han, M. S., & Mirkin, C. A. (2006) · Science · doi:10.1126/science.1125559 · Cited by 1,988 · see citing works
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951 · see citing works
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800 · see citing works
Regulating the fate of mRNA: the control of cellular iron metabolism
Klausner, R. D., Rouault, T. A., & Harford, J. B. (1993) · Cell · doi:10.1016/0092-8674(93)90046-s · Cited by 1,210 · see citing works
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
Zhang, L., Chan, J. M., Gu, F., Rhee, J., Wang, A. Z., Radovic‐Moreno, A. F., Alexis, F., Langer, R., & Farokhzad, O. C. (2008) · ACS Nano · doi:10.1021/nn800275r · Cited by 1,042 · see citing works
Cationic liposome-mediated RNA transfection.
Malone, R. W., Felgner, P. L., & Verma, I. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6077 · Cited by 911 · see citing works
The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer
Farhood, H., Serbina, N. V., & Huang, L. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)80016-9 · Cited by 799 · see citing works
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733 · see citing works
Zangi, L., Lui, K. O., von Gise, A., Ma, Q., Ebina, W., Ptaszek, L. M., Später, D., Xu, H., Tabebordbar, M., Gorbatov, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2682 · Cited by 646 · see citing works
Holtkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., Türeci, O., & Sahin, U. (2006) · Blood · doi:10.1182/blood-2006-04-015024 · Cited by 625 · see citing works
Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif
D’Souza, S. E., Ginsberg, M. H., & Plow, E. F. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90096-e · Cited by 609 · see citing works
Cationic lipids, lipoplexes and intracellular delivery of genes.
Wasungu, L., & Hoekstra, D. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.024 · Cited by 575 · see citing works
Oligonucleotide Loading Determines Cellular Uptake of DNA-Modified Gold Nanoparticles
Giljohann, D. A., Seferos, D. S., Patel, P. C., Millstone, J. E., Rosi, N. L., & Mirkin, C. A. (2007) · Nano Letters · doi:10.1021/nl072471q · Cited by 553 · see citing works
5'-terminal cap structure in eucaryotic messenger ribonucleic acids
Banerjee, A. K. (1980) · Microbiological Reviews · doi:10.1128/mr.44.2.175-205.1980 · Cited by 477 · see citing works
Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform
Mandal, B., Bhattacharjee, H., Mittal, N. K., Sah, H., Balabathula, P., Thoma, L. A., & Wood, G. C. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.010 · Cited by 468 · see citing works
Van Tendeloo, V. F. I., Ponsaerts, P., Lardon, F., Nijs, G., Lenjou, M., Van Broeckhoven, C., Van Bockstaele, D. R., & Berneman, Z. N. (2001) · Blood · doi:10.1182/blood.v98.1.49 · Cited by 468 · see citing works
Layer-by-Layer Assembled Gold Nanoparticles for siRNA Delivery
Elbakry, A. M., Zaky, A. A., Liebl, R., Rachel, R., Göpferich, A. M., & Breunig, M. (2009) · Nano Letters · doi:10.1021/nl9003865 · Cited by 424 · see citing works
A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery
Chen, M., Sonaje, K., Chen, K., & Sung, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.087 · Cited by 420 · see citing works
Hatakeyama, H., Akita, H., Kogure, K., Oishi, M., Nagasaki, Y., Kihira, Y., Ueno, M., Kobayashi, H., Kikuchi, H., & Harashima, H. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302843 · Cited by 397 · see citing works
Cytoplasmic regulation of mRNA function: The importance of the 3′ untranslated region
Jackson, R. J. (1993) · Cell · doi:10.1016/0092-8674(93)90290-7 · Cited by 388 · see citing works
Weide, B., Pascolo, S., Scheel, B., Derhovanessian, E., Pflugfelder, A., Eigentler, T. K., Pawelec, G., Hoerr, I., Rammensee, H.-G., & Garbe, C. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181a00068 · Cited by 378 · see citing works
Patel, P. C., Giljohann, D. A., Daniel, W. L., Zheng, D., Prigodich, A. E., & Mirkin, C. A. (2010) · Bioconjugate Chemistry · doi:10.1021/bc1002423 · Cited by 366 · see citing works
(2001) · PubMed Central · Cited by 342 · see citing works
Fotin-Mleczek, M., Duchardt, K. M., Lorenz, C., Pfeiffer, R., Ojkić-Zrna, S., Probst, J., & Kallen, K.-J. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181f7dbe8 · Cited by 335 · see citing works
(1995) · PubMed · Cited by 330 · see citing works
Translational control by changes in poly(A) tail length: recycling mRNAs
Weill, L., Belloc, E., Bava, F.-A., & Méndez, R. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2311 · Cited by 328 · see citing works
Su, X., Fricke, J., Kavanagh, D. G., & Irvine, D. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100390w · Cited by 287 · see citing works
Read, M. L., Singh, S., Ahmed, Z., Stevenson, M., Briggs, S. S., Oupický, D., Barrett, L. B., Spice, R., Kendall, M. A. F., Berry, M., et al. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni085 · Cited by 279 · see citing works
Novel “anti-reverse” cap analogs with superior translational properties
Jemielity, J., Fowler, T. E., Zuberek, J., Stȩpiński, J., Lewdorowicz, M., Niedźwiecka-Kornaś, A., Stolarski, R., Darżynkiewicz, E., & Rhoads, R. E. (2003) · RNA · doi:10.1261/rna.5430403 · Cited by 263 · see citing works
Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
Weide, B., Carralot, J.-P., Reese, A., Scheel, B., Eigentler, T. K., Hoerr, I., Rammensee, H.-G., Garbe, C., & Pascolo, S. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31815ce501 · Cited by 261 · see citing works
Salvador-Morales, C., Zhang, L., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.005 · Cited by 251 · see citing works
Controlling liposome blood clearance by surface-grafted polymers
Woodle, M. C. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00136-1 · Cited by 242 · see citing works
The regulation of mRNA stability in mammalian cells: 2.0
Wu, X., & Brewer, G. (2012) · Gene · doi:10.1016/j.gene.2012.03.021 · Cited by 239 · see citing works
mRNA as gene therapeutic: How to control protein expression
Tavernier, G., Andries, O., Demeester, J., Sanders, N. N., De Smedt, S. C., & Rejman, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.020 · Cited by 232 · see citing works
Song, L. Y., AHKONG, Q. F., Rong, Q., Wang, Z., Ansell, S. M., Hope, M. J., & Mui, B. L. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00399-6 · Cited by 229 · see citing works
Rittig, S. M., Haentschel, M., Weimer, K. J., Heine, A., Muller, M. R., Brugger, W., Horger, M. S., Maksimovic, O., Stenzl, A., Hoerr, I., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.289 · Cited by 226 · see citing works
Bettinger, T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.18.3882 · Cited by 224 · see citing works
Perche, F., Benvegnu, T. J., Berchel, M., Lebegue, L., Pichon, C., Jaffrès, P., & Midoux, P. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.12.010 · Cited by 219 · see citing works
Lipid-based mRNA vaccine delivery systems
Midoux, P., & Pichon, C. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.986104 · Cited by 209 · see citing works
Scheel, B., Teufel, R., Probst, J., Carralot, J., Geginat, J., Radsak, M. P., Jarrossay, D., Wagner, H., Jung, G., Rammensee, H., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200425656 · Cited by 198 · see citing works
Shi, J., Xiao, Z., Votruba, A. R., Vilos, C., & Farokhzad, O. C. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101554 · Cited by 195 · see citing works
Self-citationCurrent prospects for mRNA gene delivery
Yamamoto, A., Kormann, M., Rosenecker, J., & Rudolph, C. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.016 · Cited by 193 · see citing works
Identification of the gene for an Escherichia coli poly(A) polymerase.
Cao, G. J., & Sarkar, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10380 · Cited by 193 · see citing works
Wang, Y.-H., Su, H.-H., Yang, Y., Hu, Y.-X., Zhang, L., Blancafort, P., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2012.250 · Cited by 189 · see citing works
5'-terminal cap structure in eucaryotic messenger ribonucleic acids.
Banerjee, A. K. (1980) · Microbiological Reviews · doi:10.1128/mmbr.44.2.175-205.1980 · Cited by 188 · see citing works
Lipid-coated polymeric nanoparticles for cancer drug delivery
Krishnamurthy, S., Vaiyapuri, R., Zhang, L., & Chan, J. M. (2015) · Biomaterials Science · doi:10.1039/c4bm00427b · Cited by 181 · see citing works
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
Deering, R. P., Kommareddy, S., Ulmer, J. B., Brito, L. A., & Geall, A. J. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.901308 · Cited by 177 · see citing works
Polymeric nanoparticles for pulmonary protein and DNA delivery
Menon, J. U., Ravikumar, P., Pise, A., Gyawali, D., Hsia, C. C. W., & Nguyen, K. T. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.01.033 · Cited by 174 · see citing works
Kim, J., Park, J., Kim, H., Singha, K., & Kim, W. J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.072 · Cited by 168 · see citing works
Mockey, M., Gonçalves, C., Dupuy, F. P., Lemoine, F. M., Pichon, C., & Midoux, P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.105 · Cited by 165 · see citing works
Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells
Zou, S., Scarfo, K. A., Nantz, M. H., & Hecker, J. G. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.019 · Cited by 161 · see citing works
Mockey, M., Bourseau, E., Voshavar, C., Chaudhuri, A., Lafosse, S., Cam, É. L., Quesniaux, V. F. J., Ryffel, B., Pichon, C., & Midoux, P. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701072 · Cited by 161 · see citing works
Phua, K. K. L., Leong, K. W., & Nair, S. K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.029 · Cited by 159 · see citing works
Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells
Grudzien‐Nogalska, E., Jemielity, J., Kowalska, J., Darżynkiewicz, E., & Rhoads, R. E. (2007) · RNA · doi:10.1261/rna.701307 · Cited by 152 · see citing works
Reverse 5' caps in RNAs made in vitro by phage RNA polymerases.
Pasquinelli, A. E., Dahlberg, J. E., & Lund, E. (1995) · PubMed · Cited by 148 · see citing works
Lipid- and Polymer-Based Nanostructures for Cancer Theranostics
Luk, B. T., Fang, R. H., & Zhang, L. (2012) · Theranostics · doi:10.7150/thno.4381 · Cited by 147 · see citing works
Sebastian, M., Papachristofilou, A., Weiß, C., Früh, M., Cathomas, R. L., Hilbe, W., Wehler, T., Rippin, G., Koch, S. D., Scheel, B., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-748 · Cited by 142 · see citing works
Development of Multinuclear Polymeric Nanoparticles as Robust Protein Nanocarriers
Wu, J., Kamaly, N., Shi, J., Zhao, L., Xiao, Z., Hollett, G., John, R. A., Ray, S., Xu, X., Zhang, X., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201404766 · Cited by 141 · see citing works
Self-citationImmunostimulating capacities of stabilized RNA molecules
Scheel, B., Braedel, S., Probst, J., Carralot, J., Wagner, H., Schild, H., Jung, G., Rammensee, H., & Pascolo, S. (2004) · European Journal of Immunology · doi:10.1002/eji.200324198 · Cited by 138 · see citing works
mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers
Rejman, J., Tavernier, G., Bavarsad, N., Demeester, J., & Smedt, S. C. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.124 · Cited by 133 · see citing works
Magnetic field activated lipid–polymer hybrid nanoparticles for stimuli-responsive drug release
Kong, S. D., Sartor, M., Hu, C. J., Zhang, W., Zhang, L., & Jin, S. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.11.006 · Cited by 125 · see citing works
Quantitative Assessment of mRNA Cap Analogues as Inhibitors of in Vitro Translation
Cai, A., Jankowska‐Anyszka, M., Centers, A., Chlebicka, L., Stȩpiński, J., Stolarski, R., Darżynkiewicz, E., & Rhoads, R. E. (1999) · Biochemistry · doi:10.1021/bi9830213 · Cited by 123 · see citing works
Heyes, J. A., Hall, K., Tailor, V., Lenz, R., & MacLachlan, I. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.012 · Cited by 123 · see citing works
Multifunctional triblock copolymers for intracellular messenger RNA delivery
Cheng, C., Convertine, A. J., Stayton, P. S., & Bryers, J. D. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.020 · Cited by 123 · see citing works
Cellular Uptake of Gold Nanoparticles Passivated with BSA−SV40 Large T Antigen Conjugates
Ryan, J. A., Overton, K. W., Speight, M. E., Oldenburg, C. N., Loo, L., Robarge, W. P., Franzen, S., & Feldheim, D. L. (2007) · Analytical Chemistry · doi:10.1021/ac0715524 · Cited by 120 · see citing works
Kallen, K., & Theß, A. (2013) · Therapeutic Advances in Vaccines · doi:10.1177/2051013613508729 · Cited by 120 · see citing works
Effect of “helper lipid” on lipoplex electrostatics
Hirsch‐Lerner, D., Zhang, M., Eliyahu, H., Ferrari, M. E., Wheeler, C. J., & Barenholz, Y. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.04.008 · Cited by 119 · see citing works
Dewitte, H., Lint, S. V., Heirman, C., Thielemans, K., Smedt, S. C. D., Breckpot, K., & Lentacker, I. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.011 · Cited by 118 · see citing works
Single-cell mRNA transfection studies: Delivery, kinetics and statistics by numbers
Leonhardt, C., Schwake, G., Stögbauer, T. R., Rappl, S., Kuhr, J.-T., Ligon, T. S., & Rädler, J. O. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.11.008 · Cited by 117 · see citing works
Efficient genetic modification of murine dendritic cells by electroporation with mRNA
Meirvenne, S. V., Straetman, L., Heirman, C., Dullaers, M., Greef, C. D., Tendeloo, V. F. V., & Thielemans, K. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700499 · Cited by 117 · see citing works
Temmerman, M. D., Dewitte, H., Vandenbroucke, R. E., Lucas, B., Libert, C., Demeester, J., Smedt, S. C. D., Lentacker, I., & Rejman, J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.024 · Cited by 116 · see citing works
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
Rausch, S., Schwentner, C., Stenzl, A., & Bedke, J. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29553 · Cited by 115 · see citing works
Poly(A) Tail Length-dependent Stabilization of GAP-43 mRNA by the RNA-binding Protein HuD
Beckel-Mitchener, A. C., Miera, A., Keller, R., & Perrone-Bizzozero, N. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201982200 · Cited by 113 · see citing works
Effect of PEGylation on Biodistribution and Gene Silencing of siRNA/Lipid Nanoparticle Complexes
Bao, Y., Jin, Y., Chivukula, P., Zhang, J., Liu, Y., Liu, J., Clamme, J., Mahato, R. I., Ng, D., Ying, W., et al. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0874-6 · Cited by 107 · see citing works
Fotin‐Mleczek, M., Zanzinger, K., Heidenreich, R., Lorenz, C., Thess, A., Duchardt, K. M., & Kallen, K. (2012) · The Journal of Gene Medicine · doi:10.1002/jgm.2605 · Cited by 103 · see citing works
Hybrid lipid–polymer nanoparticles for sustained siRNA delivery and gene silencing
Shi, J., Xu, Y., Xu, X., Zhu, X. D., Pridgen, E. M., Wu, J., Votruba, A. R., Swami, A., Zetter, B. R., & Farokhzad, O. C. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.03.006 · Cited by 102 · see citing works
Self-citationClawson, C., Ton, L., Aryal, S., Fu, V., Esener, S. C., & Zhang, L. (2011) · Langmuir · doi:10.1021/la202123e · Cited by 93 · see citing works
Nava-Arzaluz, M. G., Piñón‐Segundo, E., Ganem‐Rondero, A., & Lechuga‐Ballesteros, D. (2012) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221112802652633 · Cited by 89 · see citing works
Karikó, K., Kuo, A., & Barnathan, E. S. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300930 · Cited by 89 · see citing works
SCHWARTZ, D., Decker, C. J., & Parker, R. (2003) · RNA · doi:10.1261/rna.2171203 · Cited by 86 · see citing works
Surface engineering of gold nanoparticles for in vitro siRNA delivery
Zhao, E.-Y., Zhao, Z.-X., Wang, J., Yang, C., Chen, C., Gao, L., Feng, Q., Hou, W., Gao, M., & Zhang, Q. (2012) · Nanoscale · doi:10.1039/c2nr31290e · Cited by 85 · see citing works
Granstein, R. D., Ding, W., & Ozawa, H. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00929.x · Cited by 81 · see citing works
Nallagatla, S. R., Toroney, R., & Bevilacqua, P. C. (2008) · RNA Biology · doi:10.4161/rna.5.3.6839 · Cited by 78 · see citing works
Zohra, F. T., Chowdhury, E. H., Tada, S., Hoshiba, T., & Akaike, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.059 · Cited by 71 · see citing works
Messenger RNA (mRNA) nanoparticle tumour vaccination
Phua, K. K. L., Nair, S. K., & Leong, K. W. (2014) · Nanoscale · doi:10.1039/c4nr01346h · Cited by 70 · see citing works
Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles
Kim, J., Yeom, J., Ko, J., Han, M. S., Lee, K., Na, S.-Y., & Bae, J. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.07.014 · Cited by 69 · see citing works
Anderson, D. M., Hall, L. L., Ayyalapu, A. R., Irion, V. R., Nantz, M. H., & Hecker, J. G. (2003) · Human Gene Therapy · doi:10.1089/10430340360535751 · Cited by 66 · see citing works
Wasungu, L., Stuart, M. C. A., Scarzello, M., Engberts, J. B. F. N., & Hoekstra, D. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.06.019 · Cited by 62 · see citing works
Markov, O. V., Mironova, N. L., Maslov, M. A., Petukhov, I. A., Morozova, N. G., Vlassov, V. V., & Аркадьевна, З. М. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.034 · Cited by 61 · see citing works
Synthetic mRNAs with Superior Translation and Stability Properties
Grudzien‐Nogalska, E., Kowalska, J., Su, W., Kuhn, A. N., Slepenkov, S. V., Darżynkiewicz, E., Şahin, U., Jemielity, J., & Rhoads, R. E. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5_4 · Cited by 59 · see citing works
High performance mRNA transfection through carbonate apatite–cationic liposome conjugates
Zohra, F. T., Chowdhury, E. H., & Akaike, T. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.050 · Cited by 58 · see citing works
Polymeric nanoparticle-mediated silencing of CD44 receptor in CD34+ acute myeloid leukemia cells
Gül-Uludağ, H., Valencia‐Serna, J., Kucharski, C., Marquez‐Curtis, L. A., Jiang, X., Larratt, L. M., Janowska‐Wieczorek, A., & Uludağ, H. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.08.008 · Cited by 52 · see citing works
Yeom, J., Ryou, S.-M., Won, M., Park, M., Bae, J., & Lee, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075369 · Cited by 51 · see citing works
PEGylation Improves Nanoparticle Formation and Transfection Efficiency of Messenger RNA
Üzgün, S., Nica, G., Pfeifer, C., Bosinco, M., Michaelis, K., Lutz, J., Schneider, M., Rosenecker, J., & Rudolph, C. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0464-z · Cited by 50 · see citing works
Synthetic mRNAs for manipulating cellular phenotypes: an overview
Quabius, E. S., & Krupp, G. (2014) · New Biotechnology · doi:10.1016/j.nbt.2014.04.008 · Cited by 47 · see citing works
Delivery of shRNA using gold nanoparticle–DNA oligonucleotide conjugates as a universal carrier
Ryou, S.-M., Kim, S., Jang, H. H., Kim, J., Yeom, J., Eom, M. S., Bae, J., Han, M. S., & Lee, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.115 · Cited by 45 · see citing works
Strenkowska, M., Kowalska, J., Łukaszewicz, M., Zuberek, J., Su, W., Rhoads, R. E., Darżynkiewicz, E., & Jemielity, J. (2010) · New Journal of Chemistry · doi:10.1039/b9nj00644c · Cited by 42 · see citing works
Piñón‐Segundo, E., Nava-Arzaluz, M. G., & Lechuga‐Ballesteros, D. (2012) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221112802652606 · Cited by 42 · see citing works
Shi, J., Xiao, Z., Votruba, A. R., Vilos, C., & Farokhzad, O. C. (2011) · Angewandte Chemie · doi:10.1002/ange.201101554 · Cited by 41 · see citing works
Self-citationMulti-Level Kinetic Model of mRNA Delivery via Transfection of Lipoplexes
Ligon, T. S., Leonhardt, C., & Rädler, J. O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107148 · Cited by 35 · see citing works
mRNA Transfection of Mouse and Human Neural Stem Cell Cultures
McLenachan, S., Zhang, D., Palomo, A. B. A., Edel, M. J., & Chen, F. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083596 · Cited by 33 · see citing works
Interaction of Poliovirus-Specific RNAs with HeLa Cells and E. coli
Koch, G. (1973) · Modern aspects of electrochemistry · doi:10.1007/978-3-642-65772-6_4 · Cited by 32 · see citing works
Kübler, H. R., Maurer, T., Stenzl, A., Feyerabend, S., Steiner, U., Schostak, M., Schultze‐Seemann, W., Dorp, F. V., Pilla, L., Viatali, G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.4535 · Cited by 31 · see citing works
Programming Human Dendritic Cells with mRNA
Lee, J. W., Boczkowski, D., & Nair, S. K. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5_8 · Cited by 31 · see citing works
Drastic effect of nanoapatite particles on liposome-mediated mRNA delivery to mammalian cells
Zohra, F. T., Chowdhury, E. H., Nagaoka, M., & Akaike, T. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.06.031 · Cited by 26 · see citing works
In Vivo and In Vitro Analysis of Poly(A) Length Effects on mRNA Translation
Peng, J., Murray, E. L., & Schoenberg, D. R. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-033-1_15 · Cited by 23 · see citing works
Ranade, A. A., Bapsy, P. P., Nag, S. M., Digumarti, R., Raina, V., Advani, S. H., Patil, S., Maru, A., Gangadharan, V. P., Goswami, C., et al. (2012) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12035 · Cited by 21 · see citing works
Zohra, F. T., Maitani, Y., & Akaike, T. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.111 · Cited by 21 · see citing works
Nature Biotechnology's academic spinouts of 2013
Bouchie, A. J., Allison, M., Webb, S., & DeFrancesco, L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2846 · Cited by 14 · see citing works
Transient Gene Expression in Tobacco using Gibson Assembly and the Gene Gun
Mattozzi, M. D., Voges, M. J. E. E. E., Silver, P. A., & Way, J. C. (2014) · Journal of Visualized Experiments · doi:10.3791/51234 · Cited by 8 · see citing works
Kallen, K., Gnad-Vogt, U., Scheel, B., Rippin, G., & Stenzl, A. (2013) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-1-s1-p219 · Cited by 6 · see citing works
Kübier, H., Stenzl, A., Schultze‐Seemann, W., Dorp, F. V., Pilla, L., Hampel, C., Jocham, D., Center for Cancer Research and Therapeutic Development, & Miller, K. (2011) · European Journal of Cancer · doi:10.1016/s0959-8049(11)71997-9 · Cited by 4 · see citing works
Hoerr, I. (2000) · doi:10.1002/1521-4141(200001)30:1
Harvie (2000) · doi:10.1002/(sici)1520-6017(200005)89:5
Flagged first, then by citations
Research works printed but not linked: 17
- [9]Grudzien-Nogalska E Kowalska J Su W Kuhn AN Slepenkov SV Darzynkiewicz E Sahin U Jemielity J Rhoads RE Methods Mol. Biol 2013 969 55 72 23296927
- [11]Stepinski J Waddell C Stolarski R Darzynkiewicz E Rhoads RE RNA 2001 7 1486 1495 11680853 PMC1370192
- [13]Grudzien-Nogalska E Jemielity J Kowalska J Darzynkiewicz E Rhoads RE RNA 2007 13 1745 1755 17720878 PMC1986804
- [22]Dewitte H Van Lint S Heirman C Thielemans K De Smedt SC Breckpot K Lentacker I J. Control. Release 2014 194c 28 36 25151979
- [35]Pasquinelli AE Dahlberg JE Lund E RNA 1995 1 957 967 8548660 PMC1369344
- [51]Fotin-Mleczek M Duchardt KM Lorenz C Pfeiffer R Ojkic-Zrna S Probst J Kallen KJ J. Immunother 2011 34 1 15 21150709
- [52]Fotin-Mleczek M Zanzinger K Heidenreich R Lorenz C Thess A Duchardt KM Kallen KJ J. Gene Med 2012 14 428 439 22262664
- [67]Immordino ML Dosio F Cattel L Int J Nanomedicine 2006 1 297 315 17717971 PMC2426795
- [73]Hirsch-Lerner D Zhang M Eliyahu H Ferrari ME Wheeler CJ Barenholz Y Biochim Biophys Acta 2005 1714 71 84 16051183
- [77]D'Souza SE Ginsberg MH Plow EF Trends Biochem. Sci 1991 16 246 250 1926332
- [90]Pinon-Segundo E Nava-Arzaluz MG Lechuga-Ballesteros D Recent Pat Drug Deliv Formul 2012 6 224 235 22734870
- [94]Zhang L Chan JM Gu FX Rhee J-W Wang AZ Radovic-Moreno AF Alexis F Langer R Farokhzad OC ACS nano 2008 2 1696 1702 19206374 PMC4477795
- [99]Salvador-Morales C Zhang L Langer R Farokhzad OC Biomaterials 2009 30 2231 2240 19167749 PMC2699891
- [100]Owens DE Iii Peppas NA Int J Pharm 2006 307 93 102 16303268
- [106]Su X Fricke J Kavanagh DG Irvine DJ Mol. Pharm 2011 8 774 787 21417235 PMC3354687
- [119]Conry RM LoBuglio AF Wright M Sumerel L Pike MJ Johanning F Benjamin R Lu D Curiel DT Cancer Res 1995 55 1397 1400 7882341
- [129]Anderson DM Hall LL Ayyalapu AR Irion VR Nantz MH Hecker JG Hum. Gene Ther 2003 14 191 202 12639300
Cited by
Sorted by citations
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873 · see citing works
Self-citationIntracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts
Stewart, M. P., Langer, R., & Jensen, K. F. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00678 · Cited by 748 · see citing works
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
Billingsley, M. M., Singh, N., Ravikumar, P., Zhang, R., June, C. H., & Mitchell, M. J. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04246 · Cited by 636 · see citing works
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., & Thakur, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020102 · Cited by 584 · see citing works
The challenge and prospect of mRNA therapeutics landscape
Weng, Y., Li, C., Yang, T., Hu, B., Zhang, M., Guo, S., Xiao, H., Liang, X.-J., & Huang, Y. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107534 · Cited by 417 · see citing works
Islam, M. A., Xu, Y., Tao, W., Ubellacker, J. M., Lim, M., Aum, D., Lee, G. Y., Zhou, K., Zope, H., Yu, M., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0284-0 · Cited by 339 · see citing works
Self-citationNucleic acid delivery for therapeutic applications
Gupta, A., Andresen, J. L., Manan, R. S., & Langer, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113834 · Cited by 339 · see citing works
Kong, N., Tao, W., Ling, X., Wang, J., Xiao, Y., Shi, S., Ji, X., Shajii, A., Gan, S. T., Kim, N. Y., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1565 · Cited by 314 · see citing works
Self-citationMcKinlay, C. J., Vargas, J. R., Blake, T. R., Hardy, J. W., Kanada, M., Contag, C. H., Wender, P. A., & Waymouth, R. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614193114 · Cited by 288 · see citing works
Billingsley, M. M., Gong, N., Mukalel, A. J., Thatte, A. S., El-Mayta, R. D., Patel, S. K., Metzloff, A. E., Swingle, K. L., Han, X., Xue, L., et al. (2023) · Small · doi:10.1002/smll.202304378 · Cited by 286 · see citing works
Nanomedicines for renal disease: current status and future applications
Kamaly, N., He, C., Ausiello, D. A., & Farokhzad, O. C. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.156 · Cited by 253 · see citing works
Zhang, H., You, X., Wang, X., Cui, L., Wang, Z., Xu, F., Li, M., Yang, Z., Liu, J., Huang, P., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005191118 · Cited by 251 · see citing works
Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
Gómez-Aguado, I., Rodríguez-Castejón, J., Vicente-Pascual, M., Rodríguez‐Gascón, A., Solinís, M. Á., & del Pozo‐Rodríguez, A. (2020) · Nanomaterials · doi:10.3390/nano10020364 · Cited by 224 · see citing works
Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening
Guimarães, P. P. G., Zhang, R., Spektor, R., Tan, M., Chung, A., Billingsley, M. M., El-Mayta, R. D., Riley, R., Wang, L., Wilson, J. M., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.028 · Cited by 219 · see citing works
Islam, M. A., Jamie, R., Reesor, E., Zope, H. R., Tao, W., Lim, M., Ding, J., Chen, Y., Aduluso, D., Zetter, B. R., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120431 · Cited by 218 · see citing works
Self-citationSedic, M., Senn, J. J., Lynn, A., Laska, M., Smith, M., Platz, S. J., Bolen, J., Hoge, S., Bulychev, A., Jacquinet, E., et al. (2018) · Veterinary Pathology · doi:10.1177/0300985817738095 · Cited by 195 · see citing works
Polymer‐Based mRNA Delivery Strategies for Advanced Therapies
Yang, W., Mixich, L., Boonstra, E., & Cabral, H. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202688 · Cited by 190 · see citing works
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing
Zhang, X., Zhao, W., Nguyen, G. N., Zhang, C., Zeng, C., Yan, J., Du, S., Hou, X., Li, W., Jiang, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc2315 · Cited by 183 · see citing works
Billingsley, M. M., Hamilton, A. G., Mai, D., Patel, S. K., Swingle, K. L., Sheppard, N. C., June, C. H., & Mitchell, M. J. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c02503 · Cited by 180 · see citing works
RNA Nanotechnology-Mediated Cancer Immunotherapy
Lin, Y., Wang, Y., Blake, S., Yu, M., Mei, L., Wang, H., & Shi, J. (2019) · Theranostics · doi:10.7150/thno.35568 · Cited by 173 · see citing works
Self-citationNanoscale platforms for messenger RNA delivery
Li, B., Zhang, X., & Dong, Y. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1530 · Cited by 170 · see citing works
Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing
Qiu, M., Li, Y., Bloomer, H., & Xu, Q. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00500 · Cited by 168 · see citing works
Nanomaterial-Enabled Cancer Therapy
Quader, S., & Kataoka, K. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.04.026 · Cited by 156 · see citing works
Effects of Chemically Modified Messenger RNA on Protein Expression
Li, B., Luo, X. L., & Dong, Y. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00090 · Cited by 154 · see citing works
Granot-Matok, Y., & Peer, D. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.015 · Cited by 154 · see citing works
Exosome for mRNA delivery: Strategies and therapeutic applications
Iqbal, Z., Rehman, K., Mahmood, A., Shabbir, M., Liang, Y., Duan, L., & Zeng, H. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02634-x · Cited by 144 · see citing works
Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo
Zhu, X., Tao, W., Liu, D. X., Wu, J., Guo, Z., Ji, X., Bharwani, Z., Zhao, L., Zhao, X., Farokhzad, O. C., et al. (2017) · Theranostics · doi:10.7150/thno.18136 · Cited by 134 · see citing works
Self-citationGao, C., Cheng, K., Li, Y., Gong, R., Zhao, X., Nie, G., & Ren, H. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c01994 · Cited by 134 · see citing works
Vaccine-like nanomedicine for cancer immunotherapy
Yi, Y., Yu, M., Li, W., Zhu, D., Mei, L., & Ou, M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.02.015 · Cited by 131 · see citing works
mRNA nanomedicine: Design and recent applications
Kubiatowicz, L. J., Mohapatra, A., Krishnan, N., Fang, R. H., & Zhang, L. (2022) · Exploration · doi:10.1002/exp.20210217 · Cited by 130 · see citing works
Development and Delivery Systems of mRNA Vaccines
Liang, Y., Huang, L., & Liu, T. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.718753 · Cited by 125 · see citing works
mRNA therapeutics deliver a hopeful message
Zhong, Z., Cafferty, S. M., Combes, F., Huysmans, H., Temmerman, J. D., Gitsels, A., Vanrompay, D. C. G., Catani, J. P., & Sanders, N. N. (2018) · Nano Today · doi:10.1016/j.nantod.2018.10.005 · Cited by 120 · see citing works
Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
Trepotec, Z., Lichtenegger, E., Plank, C., Aneja, M. K., & Rudolph, C. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.12.012 · Cited by 115 · see citing works
Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies
Lim, M., Badruddoza, A. Z. M., Firdous, J., Azad, M. A., Mannan, A., Al-Hilal, T. A., Cho, C., & Islam, M. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010030 · Cited by 114 · see citing works
Self-citationmRNA vaccines for COVID-19 and diverse diseases
Hussain, A., Yang, H., Zhang, M., Liu, Q., Alotaibi, G., Irfan, M. F., He, H., Chang, J. K., Liang, X., Weng, Y., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.032 · Cited by 117 · see citing works
Current landscape of mRNA technologies and delivery systems for new modality therapeutics
Lu, R., Hsu, H.-E., Perez, S. J. L. P., Kumari, M., Chen, G., Hong, M.-H., Lin, Y.-S., Liu, C.-H., Ko, S.-H., Concio, C. A. P., et al. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01080-z · Cited by 113 · see citing works
Lipid nanocarriers for microRNA delivery
Scheideler, M., Vidaković, I., & Prassl, R. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.104837 · Cited by 107 · see citing works
Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases
Sahu, I., Haque, A. K. M. A., Weidensee, B., Weinmann, P., & Kormann, M. S. D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.019 · Cited by 104 · see citing works
Wang, Y., Shahi, P. K., Wang, X., Xie, R., Zhao, Y., Wu, M., Roge, S., Pattnaik, B. R., & Gong, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.030 · Cited by 104 · see citing works
Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications
Patel, S., Athirasala, A., Menezes, P. D. P., Ashwanikumar, N., Zou, T., Sahay, G., & Bertassoni, L. E. (2018) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0444 · Cited by 99 · see citing works
Influence of cell size on cellular uptake of gold nanoparticles
Wang, X., Hu, X., Li, J., Mulero‐Russe, A., Kawazoe, N., Yang, Y., & Chen, G. (2016) · Biomaterials Science · doi:10.1039/c6bm00171h · Cited by 94 · see citing works
Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
Versteeg, L., Almutairi, M. M., Hotez, P. J., & Pollet, J. B. K. (2019) · Vaccines · doi:10.3390/vaccines7040122 · Cited by 93 · see citing works
Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA
Siewert, C. D., Haas, H., Cornet, V., Nogueira, S. S., Nawroth, T., Uebbing, L., Ziller, A., Al-Gousous, J., Rădulescu, A., Schroer, M. A., et al. (2020) · Cells · doi:10.3390/cells9092034 · Cited by 89 · see citing works
Enhancing the In Vitro and In Vivo Stabilities of Polymeric Nucleic Acid Delivery Nanosystems
Wang, Y., Ye, M., Xie, R., & Gong, S. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00749 · Cited by 88 · see citing works
A new developing class of gene delivery: messenger RNA-based therapeutics
Zhao, M., Ahern, J. O., Lyu, J., Pierucci, L., Zhou, D., & Wang, W. (2017) · Biomaterials Science · doi:10.1039/c7bm00712d · Cited by 86 · see citing works
Wang, Y., Song, H., Yu, M., Xu, C., Liu, Y., Tang, J., Yang, Y., & Yu, C. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00544c · Cited by 85 · see citing works
Lipid Polymer Hybrid Nanomaterials for mRNA Delivery
Zhao, W., Zhang, C., Li, B., Zhang, X., Luo, X. L., Zeng, C., Li, W., Gao, M., & Dong, Y. (2018) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-018-0536-9 · Cited by 85 · see citing works
RNA delivery biomaterials for the treatment of genetic and rare diseases
Zhao, W., Hou, X., Vick, O. G., & Dong, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119291 · Cited by 82 · see citing works
Yasar, H., Biehl, A., Rossi, C. D., Koch, M., Murgia, X., Loretz, B., & Lehr, C. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0401-y · Cited by 77 · see citing works
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
Titze-de-Almeida, S. S., Soto‐Sánchez, C., Fernández, E., Koprich, J. B., Brotchie, J. M., & Titze‐de‐Almeida, R. (2020) · Cells · doi:10.3390/cells9040841 · Cited by 76 · see citing works
Wang, Y., Ma, B., Abdeen, A. A., Chen, G., Xie, R., Saha, K., & Gong, S. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b09642 · Cited by 74 · see citing works
Advances in Nanoparticles for Effective Delivery of RNA Therapeutics
Byun, M. J., Lim, J., Kim, S.-N., Park, D.-H., Kim, T. P., Park, W., & Park, C. G. (2022) · BioChip Journal · doi:10.1007/s13206-022-00052-5 · Cited by 76 · see citing works
Bukhari, S. N. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040866 · Cited by 74 · see citing works
Cai, K., Wang, A. Z., Yin, L., & Cheng, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.034 · Cited by 73 · see citing works
Nanomaterials for mRNA ‐based therapeutics: Challenges and opportunities
Li, D., Liu, Q., Yang, M., Xu, H., Zhu, M., Zhang, Y., Xu, J., Tian, C., Yao, J., Wang, L., et al. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10492 · Cited by 71 · see citing works
mRNA-based therapeutics–Advances and perspectives
Sergeeva, O. V., Koteliansky, V., & Zatsepin, T. S. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916070075 · Cited by 72 · see citing works
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles
Ouranidis, A., Vavilis, T., Mandala, E., Davidopoulou, C., Stamoula, Ε., Markopoulou, C. K., Karagianni, A., & Kachrimanis, K. (2021) · Biomedicines · doi:10.3390/biomedicines10010050 · Cited by 72 · see citing works
Yu, Y., Bu, F., Zhou, H., Wang, Y., Cui, J., Wang, X., Nie, G., & Xiao, H. (2020) · Materials Chemistry Frontiers · doi:10.1039/d0qm00255k · Cited by 71 · see citing works
Li, J., Ghatak, S., Masry, M. S. E., Das, A., Liu, Y., Roy, S., Lee, R. J., & Sen, C. K. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.04.021 · Cited by 66 · see citing works
Non-viral strategies for delivering genome editing enzymes
Li, J., Røise, J. J., He, M., Das, R., & Murthy, N. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.004 · Cited by 63 · see citing works
Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice
Schoellhammer, C. M., Lauwers, G. Y., Goettel, J. A., Oberli, M. A., Cleveland, C., Park, J. Y., Minahan, D. J., Chen, Y., Anderson, D. G., Jaklenec, A., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.002 · Cited by 62 · see citing works
Zhang, C., Zhang, X., Zhao, W., Zeng, C., Li, W., Li, B., Luo, X., Li, J., Jiang, J., Deng, B., et al. (2019) · Nano Research · doi:10.1007/s12274-019-2308-9 · Cited by 61 · see citing works
Therapeutic mRNA delivery to leukocytes
Granot-Matok, Y., Kon, E., Dammes, N., Mechtinger, G., & Peer, D. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.032 · Cited by 61 · see citing works
Guevara, M. L., Jilesen, Z., Stojdl, D., & Persano, S. (2019) · ACS Omega · doi:10.1021/acsomega.9b00489 · Cited by 58 · see citing works
A polyphenol-assisted IL-10 mRNA delivery system for ulcerative colitis
Chen, Z., Hao, W., Gao, C., Zhou, Y. Y., Zhang, C., Zhang, J., Wang, R., Wang, Y., & Wang, S. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.025 · Cited by 58 · see citing works
Manufacturing Cell Therapies Using Engineered Biomaterials
Abdeen, A. A., & Saha, K. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.06.008 · Cited by 55 · see citing works
Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy
Ruan, S., Huang, Y., He, M., & Gao, H. (2022) · Advanced Science · doi:10.1002/advs.202200027 · Cited by 54 · see citing works
A scalable and robust cationic lipid/polymer hybrid nanoparticle platform for mRNA delivery
Meyer, R. A., Hussmann, G. P., Peterson, N. C., Santos, J. L., & Tuesca, A. D. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121314 · Cited by 55 · see citing works
Transdermal delivery for gene therapy
Singh, P., Muhammad, I., Nelson, N. E., Tran, K. T. M., Vinikoor, T., Chorsi, M. T., D’Orio, E., & Nguyen, T. D. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01138-1 · Cited by 52 · see citing works
Dendrimer-Mediated Delivery of DNA and RNA Vaccines
Kisakova, L. A., Apartsin, E. K., Nizolenko, L. F., & Карпенко, Л. И. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041106 · Cited by 52 · see citing works
Emerging Concepts of Nanobiotechnology in mRNA Delivery
Wang, Y., & Yu, C. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202003545 · Cited by 52 · see citing works
Transcellular delivery of messenger RNA payloads by a cationic supramolecular MOF platform
Sun, P., Li, Z., Wang, J., Gao, H., Yang, X., Wu, S., Liu, D., & Chen, Q. (2018) · Chemical Communications · doi:10.1039/c8cc07047d · Cited by 51 · see citing works
Wei, D., Jiang, M., Lin, P., Yang, H., Dang, Y., Qiao, Y., Liao, D., Luo, D., & Chen, G. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4660 · Cited by 48 · see citing works
Dynamic mRNA polyplexes benefit from bioreducible cleavage sites for in vitro and in vivo transfer
Levačić, A. K., Berger, S., Müller, J., Wegner, A., Lächelt, U., Dohmen, C., Rudolph, C., & Wagner, E. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.016 · Cited by 47 · see citing works
mRNA delivery in cancer immunotherapy
Zhong, Y., Du, S., & Dong, Y. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.03.001 · Cited by 48 · see citing works
Transfection by cationic gemini lipids and surfactants
Damen, M., Groenen, A., van Dongen, S. F. M., Nolte, R. J. M., Scholte, B. J., & Feiters, M. C. (2018) · MedChemComm · doi:10.1039/c8md00249e · Cited by 46 · see citing works
Nanomaterials innovation as an enabler for effective cancer interventions
Russell, L. M., Liu, C. H., & Grodzinski, P. A. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119926 · Cited by 45 · see citing works
Effects of local structural transformation of lipid-like compounds on delivery of messenger RNA
Li, B., Luo, X. L., Deng, B., Giancola, J. B., McComb, D. W., Schmittgen, T. D., & Dong, Y. (2016) · Scientific Reports · doi:10.1038/srep22137 · Cited by 44 · see citing works
Polymers and hydrogels for local nucleic acid delivery
Fliervoet, L. A. L., Engbersen, J. F. J., Schiffelers, R. M., Hennink, W. E., & Vermonden, T. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01795f · Cited by 44 · see citing works
Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy
García-Fernández, C., Fornaguera, C., & Borrós, S. (2020) · Cancers · doi:10.3390/cancers12061609 · Cited by 44 · see citing works
Hepatocellular-Targeted mRNA Delivery Using Functionalized Selenium Nanoparticles In Vitro
Singh, D., & Singh, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030298 · Cited by 44 · see citing works
Zhao, M., Zhu, T., Chen, J., Cui, Y., Zhang, X., Lee, R. J., Sun, F., Li, Y., & Teng, L. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120204 · Cited by 43 · see citing works
Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA
Schumann, C., Nguyen, D. X., Norgard, M. A., Bortnyak, Y., Korzun, T., Chan, S., Lorenz, A. S., Moses, A. S., Albarqi, H. A., Wong, L., et al. (2018) · Theranostics · doi:10.7150/thno.27847 · Cited by 42 · see citing works
Correlation of mRNA delivery timing and protein expression in lipid-based transfection
Reiser, A., Woschée, D., Mehrotra, N., Krzysztoń, R., Strey, H. H., & Rädler, J. O. (2019) · Integrative Biology · doi:10.1093/intbio/zyz030 · Cited by 40 · see citing works
Ding, F., Zhang, H., Cui, J., Li, Q., & Yang, C. (2021) · Biomaterials Science · doi:10.1039/d1bm00866h · Cited by 37 · see citing works
Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease
Hadas, Y., Katz, M. G., Bridges, C. R., & Zangi, L. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1367 · Cited by 37 · see citing works
Immune Response to SARS-CoV-2 Vaccines
Bellamkonda, N., Lambe, U. P., Sawant, S. A., Nandi, S. S., Chakraborty, C., & Shukla, D. (2022) · Biomedicines · doi:10.3390/biomedicines10071464 · Cited by 35 · see citing works
Ullah, A., Khan, M., Zhang, Y., Shafiq, M., Ullah, M., Abbas, A., Xianxiang, X., Chen, G., & Diao, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s429279 · Cited by 37 · see citing works
Xu, X., Li, Y., Liang, Q., Song, Z., Li, F., He, H., Wang, J., Zhu, L., Lin, Z., & Yin, L. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b15896 · Cited by 37 · see citing works
An overview of key potential therapeutic strategies for combat in the COVID-19 battle
Das, G., Ghosh, S., Garg, S., Ghosh, S., Jana, A., Samat, R., Mukherjee, N., Roy, R., & Ghosh, S. (2020) · RSC Advances · doi:10.1039/d0ra05434h · Cited by 36 · see citing works
Application of Nanoparticle-Based siRNA and CRISPR/Cas9 Delivery Systems in Gene-Targeted Therapy
Tao, Y., Hou, X., Zuo, F., Li, X., Pang, Y., & Jiang, G. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0522 · Cited by 31 · see citing works
Rahman, M. M., Zhou, N., & Huang, J. (2021) · Vaccines · doi:10.3390/vaccines9030244 · Cited by 32 · see citing works
Non-viral nanocarriers for CRISPR-Cas9 gene editing system delivery
Tang, X., Wang, Z., Zhang, Y., Mu, W., & Han, X. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.135116 · Cited by 30 · see citing works
Zheng, N., Song, Z., Yang, J., Liu, Y., Li, F., Cheng, J., & Yin, L. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.05.001 · Cited by 30 · see citing works
The notorious R.N.A. in the spotlight - drug or target for the treatment of disease
Reautschnig, P., Vogel, P., & Stafforst, T. (2016) · RNA Biology · doi:10.1080/15476286.2016.1208323 · Cited by 29 · see citing works
Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders
Arjunan, P., Kathirvelu, D., Mahalingam, G., Goel, A., Zacharaiah, U. G., Srivastava, A., & Marepally, S. K. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.04.015 · Cited by 31 · see citing works
Zhao, Y., Wang, Z. M., Song, D., Chen, M., & Xu, Q. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102499 · Cited by 28 · see citing works
García-Fernández, C., Saz, A., Fornaguera, C., & Borrós, S. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00333-5 · Cited by 27 · see citing works
Powering up the molecular therapy of RNA interference by novel nanoparticles
Liao, W., Li, W., Zhang, T., Kirberger, M., Liu, J., Wang, P., Chen, W., & Wang, Y. (2016) · Biomaterials Science · doi:10.1039/c6bm00204h · Cited by 28 · see citing works
Assolini, J. P., Carloto, A. C. M., Bortoleti, B. T. D. S., Gonçalves, M. D., Tomiotto‐Pellissier, F., Feuser, P. E., Cordeiro, A. P., de Araújo, P. H. H., Sayer, C., Miranda-Sapla, M. M., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174934 · Cited by 27 · see citing works
- Authors
- Islam, M. A., Reesor, E. K. G., Xu, Y., Zope, H. R., Zetter, B. R., & Shi, J.
- Affiliations
- Brigham and Women's Hospital (US)
- Boston Children's Hospital (US)
- Corresponding author
- Zetter, Bruce R.
- Shi, Jinjun
- Venue
- Biomaterials Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2015
- Volume
- 3
- Issue
- 12
- Pages
- 1519-1533
- ISSN
- 2047-4830 (ISSN-L)
- 2047-4849
- PMC
- PMC4641793
- OpenAlex
- W1945220000
- Cited by
- 176
- References
- 123
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 13 · 2023: 15 · 2022: 16 · 2021: 22 · 2020: 27 · 2019: 16 · 2018: 24 · 2017: 13 · 2016: 11
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biomaterials Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- National Cancer Institute (R01 CA37393, R01CA037393, R00CA160350)
- DOD Prostate Cancer Research Program
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- mRNA delivery, biomaterials, nanotechnology, mRNA therapeutics, mRNA stability, innate immune response, mRNA degradation, nucleic acid delivery systems
- MeSH terms
- Biocompatible Materials, Biological Transport, Genetic Vectors, Humans, RNA, Messenger, Transfection, Gene Transfer Techniques, Nanotechnology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
